Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Leukemia 19Leukemia, Myeloid, Chronic-Phase 15Carcinoma, Renal Cell 15Kidney Neoplasms 13Multiple Myeloma 12Melanoma 11Neoplasms, Plasma Cell 10Lymphoma 10Pancreatic Neoplasms 9Leukemia, Myelogenous, Chronic, BCR-ABL Positive 9Lymphoma, Follicular 7Waldenstrom Macroglobulinemia 5Leukemia, Myeloid, Accelerated Phase 5Leukemia, Lymphocytic, Chronic, B-Cell 5Burkitt Lymphoma 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasms 4Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, B-Cell, Marginal Zone 4Lung Neoplasms 4Leukemia, Myeloid, Acute 4Carcinoma, Hepatocellular 4Stomach Neoplasms 3Small Cell Lung Carcinoma 3Immunoglobulin Light-chain Amyloidosis 3Carcinoma, Non-Small-Cell Lung 3Blast Crisis 3

Interventions

Ifosfamide 15Methotrexate 12Doxorubicin 12Filgrastim 10Cisplatin 10Cyclophosphamide 9Etoposide 8Gemcitabine 7cabozantinib 6apatinib 6Magnetic Resonance Spectroscopy 6Leucovorin 6X-Rays 5Specimen Handling 5Sirolimus 5Phantoms, Imaging 5Nivolumab 5Neoadjuvant Therapy 5camrelizumab 4Vincristine 4Topotecan 4Radiotherapy 4Nuclear Medicine Department, Hospital 4Drug Therapy 4Docetaxel 4Biopsy 4regorafenib 3palbociclib 3olaparib 3mifamurtide 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Osteosarcoma × Interferon-alpha × Clear all
NCT00026416 2014-01-06

Interferon Alfa and Thalidomide in Treating Patients With Soft Tissue Sarcoma or Bone Sarcoma

National Cancer Institute (NCI)

Phase 2 Unknown
Sarcoma

Sarcoma, Osteosarcoma

NCT00504140 2012-08-02

Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma

M.D. Anderson Cancer Center

Phase 2 Completed
30 enrolled
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡